AR046205A1 - Formulacion farmaceutica de licofelona - Google Patents

Formulacion farmaceutica de licofelona

Info

Publication number
AR046205A1
AR046205A1 ARP040103905A ARP040103905A AR046205A1 AR 046205 A1 AR046205 A1 AR 046205A1 AR P040103905 A ARP040103905 A AR P040103905A AR P040103905 A ARP040103905 A AR P040103905A AR 046205 A1 AR046205 A1 AR 046205A1
Authority
AR
Argentina
Prior art keywords
water soluble
pharmaceutical formulation
copolymers
soluble polymer
licofelona
Prior art date
Application number
ARP040103905A
Other languages
English (en)
Spanish (es)
Inventor
F Sievert
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of AR046205A1 publication Critical patent/AR046205A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP040103905A 2003-10-31 2004-10-27 Formulacion farmaceutica de licofelona AR046205A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10351035A DE10351035A1 (de) 2003-10-31 2003-10-31 Pharmazeutische Licofelone-Formulierung

Publications (1)

Publication Number Publication Date
AR046205A1 true AR046205A1 (es) 2005-11-30

Family

ID=34485181

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103905A AR046205A1 (es) 2003-10-31 2004-10-27 Formulacion farmaceutica de licofelona

Country Status (4)

Country Link
AR (1) AR046205A1 (de)
DE (1) DE10351035A1 (de)
TW (1) TW200524592A (de)
WO (1) WO2005041920A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109718220A (zh) * 2017-10-27 2019-05-07 天津药物研究院有限公司 Ml-4000包合物胶囊的制备方法
EP3593792A1 (de) 2018-07-11 2020-01-15 Welding GmbH & Co. KG Pharmazeutische zusammensetzung umfassend 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäurecholinsalz
WO2023089636A1 (en) * 2021-11-21 2023-05-25 Aizant Drug Research Solutions Private Limited Pharmaceutical compositions of licofelone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2247604T3 (es) * 1995-06-12 2006-03-01 G.D. SEARLE & CO. Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa.
AU1850597A (en) * 1996-02-13 1997-09-02 G.D. Searle & Co. Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors
DE10121252A1 (de) * 2001-04-30 2002-11-07 Christos C Zouboulis Behandlung der Akne
PT1505964E (pt) * 2002-05-17 2008-02-28 Merckle Gmbh Compostos de pirrole anelados como inibidores da bomba de protão para o tratamento da úlcera

Also Published As

Publication number Publication date
WO2005041920A3 (de) 2005-07-14
WO2005041920A2 (de) 2005-05-12
DE10351035A1 (de) 2005-05-25
TW200524592A (en) 2005-08-01

Similar Documents

Publication Publication Date Title
CO5261563A1 (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
ATE238813T1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
ITMI20001173A0 (it) Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva.
PE20061160A1 (es) Sistema de administracion de farmacos con retencion gastrica
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
PE20040131A1 (es) Formulaciones y formas de dosificacion para la administracion controlada de topiramato
RS50303B (sr) Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
ECSP045102A (es) Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo
AR044131A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
NO2013019I1 (no) Kombinasjon omfattende aliskiren, som den frie basen eller som et farmasøytisk akseptabelt salt derav, og hydroklortiazid eller et farmasøytisk akseptabelt salt derav.
PE20061449A1 (es) Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion
NO20024919L (no) Hydrofil/lipofil polymer matriksdoseringsformulering
BR0107869A (pt) Composições farmacêuticas eletrogiradas
ES2175799T3 (es) Forma de dosificacion para administracion en aerosol.
AR013117A1 (es) Una composicion farmaceutica solida en forma de comprimido que comprende un derivado de benzofurano con actividad antiarritmica adaptada para administracion oral
NO974194D0 (no) Forbedringer i, eller vedrörende, organiske sammensetninger
BR9814756A (pt) Composição sólida seca para liberação de droga, processo para a preparação da mesma, uso de um grande número de pequenas esferas que contêm uma matriz polimérica composta de um polietileno glicol ou de uma mistura de polietileno glicóis
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
DE602005000333D1 (de) Gegen verfärbung beständige aerosolsprays
DE602004003577D1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
EA200300110A1 (ru) Композиция элетриптана в виде частиц
AR012868A1 (es) COMPOSICIoN FARMACÉUTICA QUE COMPRENDE UN PÉPTIDO AGONISTA DE LHRH, UN ANTAGONISTA DE LHRH O UN PÉPTIDO DE GRF Y NICOTINAMIDA.
AR046205A1 (es) Formulacion farmaceutica de licofelona
SV2006001916A (es) Formulaciones farmaceuticas transdermales

Legal Events

Date Code Title Description
FB Suspension of granting procedure